{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:13:46Z","timestamp":1760058826839,"version":"build-2065373602"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004399","name":"UCB","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100004399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background\/Objective: During the systemic treatment of moderate to severe psoriasis in patients of reproductive age, contraindications and therapeutic peculiarities must be taken into account. Doctor\u2013patient communication is crucial for therapy conduct and compliance. Methods: This survey among male and female patients from the German psoriasis registry, PsoBest, aims to provide real-world evidence on communication and patient needs for those of reproductive age (18\u201355). Result: In total, 404 patients were eligible for the analysis (254 m, 150 f), including 39 patients currently wishing to conceive (20 m, 19 f). Patients with and without the desire to have children received similar systemic therapy. In most cases, treatment was not adapted when patients expressed a desire to have children (85.9% m, 79.5% f). Only 38.3% of men and 49.9% of women had been informed about options for conception during or before systemic therapy, mainly by dermatologists (77.4% m, 84.6% f). The majority of patients retrieved additional information about the wish to conceive and medications from the internet and other media. This survey emphasizes the importance of open communication between patients and physicians regarding family planning and therapy options. Conclusions: Physicians need to broach the topic of family planning, conception and pregnancy with patients and support with evidence-based information to enable comprehensive medical decision making and safe therapy choices.<\/jats:p>","DOI":"10.3390\/healthcare13091017","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:48:33Z","timestamp":1745840913000},"page":"1017","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Communication and Therapy Planning for Patients of Reproductive Age Under Immunomodulatory Treatments for Psoriasis or Psoriatic Arthritis\u2014Survey of the German National Psoriasis Registry PsoBest"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-3692","authenticated-orcid":false,"given":"Brigitte","family":"Stephan","sequence":"first","affiliation":[{"name":"Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5809-3463","authenticated-orcid":false,"given":"Christina","family":"Sorbe","sequence":"additional","affiliation":[{"name":"Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-5956","authenticated-orcid":false,"given":"Birgit-Christiane","family":"Zyriax","sequence":"additional","affiliation":[{"name":"Midwifery Science\u2014Health Services Research and Prevention, Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Schmittinger","sequence":"additional","affiliation":[{"name":"Midwifery Science\u2014Health Services Research and Prevention, Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Augustin","sequence":"additional","affiliation":[{"name":"Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Sommer","sequence":"additional","affiliation":[{"name":"Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-9961","authenticated-orcid":false,"given":"Neuza Maria Bernardino","family":"da Silva Burger","sequence":"additional","affiliation":[{"name":"Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansgar","family":"Weyergraf","sequence":"additional","affiliation":[{"name":"Outpatient and Studycenter on the Hase Gbr, 49565 Bramsche, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5004-0982","authenticated-orcid":false,"given":"Ralph","family":"von Kiedrowski","sequence":"additional","affiliation":[{"name":"Company for Medical Study & Service Selters GmbH, 56242 Selters (Westerwald), Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"K\u00fchl","sequence":"additional","affiliation":[{"name":"Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), 20251 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-0770","article-title":"Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany","volume":"90","author":"Augustin","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/exd.12437","article-title":"Psoriasis: To treat or to manage?","volume":"23","author":"Mrowietz","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","article-title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn\u2019s disease: An open randomised trial","volume":"371","author":"Baert","year":"2008","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s12634-023-2322-5","article-title":"\u201cHit hard and early\u201d bei Psoriasis","volume":"15","author":"Storre","year":"2023","journal-title":"\u00c4sthet. Dermatol. Kosmetol."},{"key":"ref_5","first-page":"934","article-title":"German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm\u2014Part 1: Treatment goals and treatment recommendations","volume":"19","author":"Nast","year":"2021","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jdv.16926","article-title":"EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris\u2014Part 2: Specific clinical and comorbid situations","volume":"35","author":"Nast","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_7","first-page":"1092","article-title":"German S3-Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm\u2014Part 2: Treatment monitoring and specific clinical or comorbid situations","volume":"19","author":"Nast","year":"2021","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_8","first-page":"CD011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: A network meta-analysis","volume":"7","author":"Sbidian","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4103\/ijd.ijd_611_23","article-title":"Patient Needs in Psoriasis Treatment and their Influencing Factors: A Nationwide Multicentre Cross-Sectional Study in China","volume":"68","author":"Ding","year":"2023","journal-title":"Indian J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/14737167.2014.914437","article-title":"Quality of life in psoriasis patients","volume":"14","author":"Augustin","year":"2014","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/humrep\/deu056","article-title":"Too old to have children? Lessons from natural fertility populations","volume":"29","author":"Eijkemans","year":"2014","journal-title":"Hum. Reprod."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1093\/rheumatology\/keab357","article-title":"Maternal and neonatal outcomes in pregnant women with psoriasis and psoriatic arthritis: A systematic review and meta-analysis","volume":"60","author":"Xie","year":"2021","journal-title":"Rheumatology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2340\/00015555-2923","article-title":"Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden","volume":"98","author":"Haerskjold","year":"2018","journal-title":"Acta Derm. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/bjd.14547","article-title":"Psoriasis and adverse pregnancy outcomes: A systematic review of observational studies","volume":"175","author":"Bobotsis","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1007\/s13555-023-01060-5","article-title":"Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis","volume":"13","author":"Luna","year":"2023","journal-title":"Dermatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e055477","DOI":"10.1136\/bmjopen-2021-055477","article-title":"Psychological (co)morbidity in patients with psoriasis: The impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns\u2014A cross-sectional study","volume":"12","author":"Augustin","year":"2022","journal-title":"BMJ Open"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"da Silva, N., Augustin, M., Langenbruch, A., Mrowietz, U., Reich, K., Tha\u00e7i, D., Boehncke, W.-H., Kirsten, N., Danckworth, A., and Sommer, R. (2020). Sex-related impairment and patient needs\/benefits in anogenital psoriasis: Difficult-to-communicate topics and their impact on patient-centred care. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0235091"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/jdv.19567","article-title":"Implementing well-being in the management of psoriasis: An expert recommendation","volume":"38","author":"Sommer","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e024877","DOI":"10.1136\/bmjopen-2018-024877","article-title":"Stigmatisation and body image impairment in dermatological patients: Protocol for an observational multicentre study in 16 European countries","volume":"8","author":"Dalgard","year":"2018","journal-title":"BMJ Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamadermatol.2023.1400","article-title":"Fertility Trends and Adverse Pregnancy Outcomes in Female Patients with Psoriasis in the UK","volume":"159","author":"Chen","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/ajd.12641","article-title":"Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration","volume":"59","author":"Rademaker","year":"2018","journal-title":"Australas. J. Dermatol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kiran, Z., Sheikh, A., Malik, S., Meraj, A., Masood, M., Ismail, S., Rashid, M.O., Shaikh, Q., Majeed, N., and Sheikh, L. (2019). Maternal characteristics and outcomes affected by hypothyroidism during pregnancy (maternal hypothyroidism on pregnancy outcomes, MHPO-1). BMC Pregnancy Childbirth, 19.","DOI":"10.1186\/s12884-019-2596-9"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70042","DOI":"10.1111\/aji.70042","article-title":"Thyroid Autoimmunity: The Treatment of Hashimoto\u2019s Disease, or the Presence of Antithyroid Antibodies Alone, in Pregnancy","volume":"93","author":"Scher","year":"2025","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/RHU.0000000000001935","article-title":"Pregnancy Outcomes in Women with Rheumatoid Arthritis: A Systematic Review and Meta-analysis","volume":"29","author":"Sim","year":"2023","journal-title":"J. Clin. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e003762","DOI":"10.1136\/rmdopen-2023-003762","article-title":"Pregnancy outcomes in women with rheumatoid arthritis: An 11-year French nationwide study","volume":"10","author":"Drouin","year":"2024","journal-title":"RMD Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00404-024-07521-2","article-title":"Obstetric outcomes of patients with inflammatory bowel disease","volume":"310","author":"Tondreau","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/jog.15136","article-title":"Pregnancy with inflammatory bowel disease: Outcomes for mothers and their children at a European tertiary care center","volume":"48","author":"Hoffmann","year":"2022","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gut.2006.108324","article-title":"A meta-analysis on the influence of inflammatory bowel disease on pregnancy","volume":"56","author":"Cornish","year":"2007","journal-title":"Gut"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.20377\/jfr-426","article-title":"Uncertainty in fertility intentions from a life course perspective: Which life course markers matter?","volume":"33","author":"Kuhnt","year":"2021","journal-title":"JFamRes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1111\/ajd.14149","article-title":"TikTok and #psoriasis: A cross-sectional study of content quality","volume":"64","author":"Aghajani","year":"2023","journal-title":"Australas. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/jech.53.2.105","article-title":"DISCERN: An instrument for judging the quality of written consumer health information on treatment choices","volume":"53","author":"Charnock","year":"1999","journal-title":"J. Epidemiol. Community Health"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1080\/09546634.2022.2037497","article-title":"Evaluating social media as a source of patient information regarding psoriasis treatments using the DISCERN instrument","volume":"33","author":"Gorrepati","year":"2022","journal-title":"J. Dermatolog. Treat."},{"key":"ref_33","first-page":"571","article-title":"Psoriasis 2.0: Facebook as a source of disease-related information for patients with psoriasis","volume":"18","author":"Schuster","year":"2020","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Peltier, M.R. (2003). Immunology of term and preterm labor. Reprod. Biol. Endocrinol., 1.","DOI":"10.1186\/1477-7827-1-122"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"102435","DOI":"10.1016\/j.eclinm.2024.102435","article-title":"Maternal-fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: A retrospective cohort study in a large U.S. healthcare system","volume":"68","author":"Hwang","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdin.2022.03.009","article-title":"Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in Denmark","volume":"7","author":"Johansen","year":"2022","journal-title":"JAAD Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamadermatol.2020.5595","article-title":"Pregnancy Outcomes in Women with Moderate-to-Severe Psoriasis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR)","volume":"157","author":"Kimball","year":"2021","journal-title":"JAMA Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Chambers, C.D., Johnson, D.L., Xu, R., Luo, Y., Lopez-Jimenez, J., Adam, M.P., Braddock, S.R., Robinson, L.K., Vaux, K., and Lyons Jones, K. (2019). Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0223603"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3899\/jrheum.140189","article-title":"Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol","volume":"42","author":"Clowse","year":"2015","journal-title":"J. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/art.40508","article-title":"Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results from a Pharmacovigilance Safety Database","volume":"70","author":"Clowse","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.14309\/ajg.0000000000002553","article-title":"Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results from the PIANO Registry","volume":"119","author":"Chugh","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1111\/bcp.15471","article-title":"Reported congenital malformations after exposure to non-tumour necrosis factor inhibitor biologics: A retrospective comparative study in EudraVigilance","volume":"88","author":"Ghalandari","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Jeong, Y.D., Jo, H., Cho, H., Jang, W., Park, J., Lee, S., Lee, H., Lee, K., Oh, J., and Wen, X. (2024). Biologics Use for Psoriasis during Pregnancy and Its Related Adverse Outcomes in Pregnant Women and Newborns: Findings from WHO Pharmacovigilance Study. Int. Arch. Allergy Immunol., 1\u201315.","DOI":"10.1159\/000542217"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2019-11-6","DOI":"10.7573\/dic.2019-11-6","article-title":"Management of psoriasis in pregnancy\u2014A review of the evidence to date","volume":"9","author":"Ferreira","year":"2020","journal-title":"Drugs Context"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00228-017-2351-y","article-title":"Drug safety in pregnancy: The German Embryotox institute","volume":"74","author":"Dathe","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/BOR.0000000000001014","article-title":"Safety of biologic agents for the management of rheumatic diseases during pregnancy","volume":"36","author":"Bermas","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/keac558","article-title":"Executive Summary: British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: Immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archderm.141.5.601","article-title":"Hormonal effect on psoriasis in pregnancy and post-partum","volume":"141","author":"Murase","year":"2005","journal-title":"Arch. Dermatol."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/9\/1017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:23:33Z","timestamp":1760030613000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/13\/9\/1017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["healthcare13091017"],"URL":"https:\/\/doi.org\/10.3390\/healthcare13091017","relation":{},"ISSN":["2227-9032"],"issn-type":[{"type":"electronic","value":"2227-9032"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}